Transurethral resection and intravesical therapy of superficial bladder tumors Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Urinary Bladder Neoplasms

abstract

  • The treatment of superficial bladder cancer is aimed at eradicating existing disease, inhibiting tumor recurrence, and preventing progression to invasion or metastasis. Transurethral resection is the primary modality, with intravesical therapy used in some cases to kill residual overt or occult carcinoma and premalignant lesions. Among the agents tested extensively, BCG appears to be more effective than mitomycin C, doxorubicin, or thiotepa, especially against carcinoma in situ. A number of questions remain to be answered about the management of this disease.

publication date

  • January 1991

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 1877115

Additional Document Info

start page

  • 525

end page

  • 8

volume

  • 18

number

  • 3